Cybin Inc N.CYBN

Alternate Symbol(s): CYBN

Healthcare Drug Manufacturers - Specialty & Generic

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

NEO:CYBN - Post by User

Cybin Inc > Too Funny...

<< Previous

Bullboard Posts

Next >>

Comment by realitycheck00on Nov 19, 2020 5:13pm

62 Views

Post# 31937508

RE:RE:RE:RE:RE:RE:Too Funny...

Looks like grey market though. They need to get up to OTCQB or OTCQX for a mass US appeal to buy the stock. I dont even know if there is a proper bid / ask on the greys for most traders.

<< Previous

Bullboard Posts

Next >>

Xplore Resources to expand position near Surge Lithium Project